|Mr. Erik Engstrom||CEO & Exec. Director||3.75M||N/A||1963|
|Mr. Nicholas Lawrence Luff||CFO & Exec. Director||2.06M||N/A||1967|
|Ms. Tracey Aiken||VP of Operations, Insurance Data Solutions & Lexisnexis Risk Solutions||N/A||N/A||N/A|
|Ms. Kumsal Bayazit Besson||Chief Exec. Officer of Scientific, Technical & Medical||N/A||N/A||1974|
|Mr. Colin Tennant||Head of Investor Relations||N/A||N/A||N/A|
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk & Business Analytics segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
RELX PLC’s ISS governance QualityScore as of 4 December 2019 is 2. The pillar scores are Audit: 1; Board: 2; Shareholder rights: 1; Compensation: 4.